Riskpilot← Back to searchSign inGet full accessVIK APOTEK AS
ASActiveOrg 989035371Røysavegen 2, 6893 Vik I SognRetail sale of pharmaceutical products · NACE 4773Est. 200613 employees
Revenue 2024
NOK 24,4M
+11% vs 2023
EBITDA margin
9.5%
+19% vs 2023
Equity ratio
37.0%
Financial strength
Net profit 2024
NOK 1,9M
+19% vs 2023
| Revenue | NOK 24,4M | +11% |
| EBITDA | NOK 2,3M | +19% |
| Net profit | NOK 1,9M | +19% |
| Total assets | NOK 7,2M | +22% |
| Equity | NOK 2,7M | +47% |
| Employees | 13 | — |
Legal name
VIK APOTEK AS
Org number
989035371
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
2. januar 2006
Share capital
NOK 100 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie og drive apotekvirksomhet samt investering og handel i tilknytning til hva hermed står i forbindelse.
Address
Røysavegen 2, 6893 Vik I Sogn
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 22 293 | 22 562 | 20 449 | 21 934 | 24 361 |
| Staff expenses | −3 131 | −3 131 | −3 216 | −3 415 | −3 290 |
| EBITDA | 1 985 | 2 222 | 1 882 | 1 957 | 2 319 |
| Depreciation & amort. | −24 | −12 | −10 | −9 | −4 |
| EBIT | 1 961 | 2 210 | 1 872 | 1 948 | 2 315 |
| Net financials | 29 | 49 | 36 | 43 | 62 |
| Profit before tax | 1 990 | 2 259 | 1 908 | 1 991 | 2 377 |
| Tax | 438 | 497 | 420 | 438 | 523 |
| Net profit | 1 552 | 1 762 | 1 488 | 1 553 | 1 854 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 712 | 5 550 | 5 070 | 5 925 | 7 204 |
| Equity | 506 | 768 | 1 256 | 1 809 | 2 663 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 206 | 4 783 | 3 814 | 4 116 | 4 541 |
| Total debt | 5 206 | 4 783 | 3 814 | 4 116 | 4 541 |
EBITDA margin
9.5%
This company
15.8%
Market median
-40% vs market
20202024
Equity ratio
37.0%
This company
38.2%
Market median
+3% vs market
20202024
Return on equity
69.6%
This company
18.4%
Market median
+278% vs market
20202024
Net profit margin
7.6%
This company
8.1%
Market median
-6% vs market
20202024
Asset turnover
3.38×
This company
1.12×
Market median
+202% vs market
20202024
Debt / equity
1.71×
This company
0.62×
Market median
-176% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OA Deputy Member | Deputy Member | 2006 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2006 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lappoteket As
VIK APOTEK AS Board members of VIK APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Oddvar A Fosse | Deputy Member | 0 companies |
| Brita A Fosse | Chairman | 0 companies |